Silexon
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $16M
Investors
- 7
About Silexon
Established in 2018 and based in Nanjing, China, Silexon is a pharmaceutical service provider that engages in the development of pharmaceutical with usage of artificial intelligence and big data technology. The company focuses on the development of artificial intelligence pharmaceutical platform. Its main products include AI4D™ platform and AI4Pat™ platform. AI4D™ platform provides drug discovery, design and development services.
Who invested in Silexon
7 investors across 3 rounds
See all investors in Silexon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Silexon
Who invested in Silexon?
Silexon has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Silexon raised?
Silexon has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Silexon last raise money?
Silexon's most recent round on record is a Series A, in Sep 2021.
What does Silexon do?
Established in 2018 and based in Nanjing, China, Silexon is a pharmaceutical service provider that engages in the development of pharmaceutical with usage of artificial intelligence and big data technology.
Where is Silexon headquartered?
Silexon is headquartered in Nanjing, China.
Which VCs invest in companies like Silexon?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Silexon's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Silexon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.